Charles River Laboratories International, Inc.

Total Valuation

Charles River Laboratories International, Inc. carries a market capitalization of 13.90B, placing it among publicly traded companies globally. Its enterprise value stands at 13.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Charles River Laboratories International, Inc. currently has 47.73M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 2.77, and the price-to-book ratio stands at 3.81.

Enterprise Valuation

On an enterprise value basis, Charles River Laboratories International, Inc. trades at an EV/EBITDA multiple of 17.94 and an EV/FCF ratio of 43.32. The EV/Sales ratio of 3.43 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 29.41 provides insight into valuation relative to core operating earnings.

Financial Position

Charles River Laboratories International, Inc. maintains a current ratio of 1.35, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 104.82, indicating elevated leverage, while an interest coverage ratio of 7.19 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Charles River Laboratories International, Inc. has paid 52.63M in income taxes, reflecting an effective tax rate of 137.72.

Stock Price Statistics

Charles River Laboratories International, Inc.'s stock has gained approximately 77.74629% over the past 52 weeks. The 50-day moving average sits at 253.11, while the 200-day moving average is 199.52.

Income Statement

Over the trailing twelve months, Charles River Laboratories International, Inc. generated 4.00B in revenue and converted that into -238.46M in net income, yielding earnings per share of -4.83. EBITDA reached 764.00M, while operating income came in at 466.12M.

Balance Sheet

Charles River Laboratories International, Inc. holds 192.03M in cash and equivalents against 3.03B in total debt, resulting in a net debt position of 2.43B. Total book value stands at 2.84B, with working capital of 394.36M providing operational flexibility.

Cash Flow

Charles River Laboratories International, Inc. produced 179.73M in operating cash flow over the past twelve months.

Margins

Charles River Laboratories International, Inc. operates with a gross margin of 32.67, reflecting its pricing power and cost economics. The operating margin of 11.66 and net profit margin of -5.96 provide insight into operational efficiency.

Dividends & Yields

Scores

Charles River Laboratories International, Inc. posts an Altman Z-Score of 3.29, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.